Navamedic ASA – Mandatory notification of trade by primary insider
Oslo, 15 March 2024: Reference is made to the stock exchange announcement published earlier today, on 15 March 2024 by Navamedic ASA (the "Company" or "Navamedic"), regarding the board of directors' resolution to increase the Company's share capital with NOK 59,200 by the issuance of 80,000 new shares, in order to facilitate the settlement of exercise of 80,000 share options in the Company. The following primary insiders have today exercised share options: Lars Hjarrand, CFO of Navamedic, has today, on March 15 2024, exercised 50,000 share options in the Company under his option